HK16087A - 3-aryloxy-3-phenylpropylamines - Google Patents
3-aryloxy-3-phenylpropylaminesInfo
- Publication number
- HK16087A HK16087A HK160/87A HK16087A HK16087A HK 16087 A HK16087 A HK 16087A HK 160/87 A HK160/87 A HK 160/87A HK 16087 A HK16087 A HK 16087A HK 16087 A HK16087 A HK 16087A
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- solution
- salt
- enantiomer
- uptake
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Photoreceptors In Electrophotography (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20649880A | 1980-11-14 | 1980-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK16087A true HK16087A (en) | 1987-02-27 |
Family
ID=22766667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK160/87A HK16087A (en) | 1980-11-14 | 1987-02-19 | 3-aryloxy-3-phenylpropylamines |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP0052492B1 (cs) |
| JP (3) | JPS57114555A (cs) |
| KR (1) | KR830007508A (cs) |
| AT (1) | ATE6422T1 (cs) |
| AU (1) | AU540707B2 (cs) |
| CA (1) | CA1181430A (cs) |
| CS (1) | CS227019B2 (cs) |
| CY (1) | CY1350A (cs) |
| DD (1) | DD201139A5 (cs) |
| DE (1) | DE3162445D1 (cs) |
| DK (1) | DK161887C (cs) |
| EG (1) | EG15458A (cs) |
| ES (1) | ES8206440A1 (cs) |
| FI (1) | FI77018C (cs) |
| GB (1) | GB2087883A (cs) |
| GR (1) | GR75395B (cs) |
| HK (1) | HK16087A (cs) |
| HU (1) | HU185475B (cs) |
| IE (1) | IE52170B1 (cs) |
| IL (1) | IL64288A (cs) |
| MY (1) | MY8700709A (cs) |
| NZ (1) | NZ198953A (cs) |
| PH (1) | PH17424A (cs) |
| PL (1) | PL233786A1 (cs) |
| PT (1) | PT73982B (cs) |
| RO (1) | RO83309B (cs) |
| SU (1) | SU1068034A3 (cs) |
| ZA (1) | ZA817863B (cs) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777291A (en) * | 1985-02-27 | 1988-10-11 | Eli Lilly And Company | Racemization process |
| US4797286A (en) * | 1985-11-12 | 1989-01-10 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulations |
| US5112619A (en) * | 1985-11-12 | 1992-05-12 | Eli Lilly And Company | Orally administerable sustained release pharmaceutical formulation |
| GB8823405D0 (en) * | 1988-10-05 | 1988-11-09 | Erba Carlo Spa | Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines |
| DK258389D0 (da) * | 1989-05-26 | 1989-05-26 | Ferrosan As | Aryloxyphenylpropylaminer, deres fremstilling og anvendelse |
| AU642582B2 (en) * | 1991-02-25 | 1993-10-21 | Eli Lilly And Company | Treatment of lower urinary tract disorders |
| WO1993000074A1 (en) * | 1991-06-26 | 1993-01-07 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| EP1208838A3 (en) * | 1991-11-15 | 2003-07-09 | Sepracor Inc. | Pure S(+)isomer fluoxetine |
| EP1013275A3 (en) * | 1991-11-26 | 2001-01-10 | Sepracor, Inc. | Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| EP0576766A1 (en) * | 1992-06-29 | 1994-01-05 | Novo Nordisk A/S | Propanolamine derivatives, their preparation and use |
| TW344661B (en) * | 1993-11-24 | 1998-11-11 | Lilly Co Eli | Pharmaceutical composition for treatment of incontinence |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| WO2000051582A2 (en) | 1999-03-01 | 2000-09-08 | Sepracor Inc. | Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| WO2000058262A1 (en) * | 1999-03-29 | 2000-10-05 | Eli Lilly And Company | Stereospecific method for preparing tomoxetine and intermediates thereof |
| EP1171417B1 (en) | 1999-04-09 | 2005-11-09 | Eli Lilly And Company | Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof |
| DE19955190A1 (de) * | 1999-11-16 | 2001-06-21 | Sanol Arznei Schwarz Gmbh | Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| GB0229583D0 (en) | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
| CA2561386A1 (en) | 2004-06-28 | 2006-01-12 | Teva Pharmaceutical Fine Chemicals S.R.L. | Enantiomerically pure atomoxetine and tomoxetine mandelate |
| US7439399B2 (en) * | 2004-06-28 | 2008-10-21 | Teva Pharmaceutical Fine Chemicals | Processes for the preparation of atomoxetine hydrochloride |
| US7473804B2 (en) | 2004-07-22 | 2009-01-06 | Teva Pharmaceutical Fine Chemicals S.R.L. | Polymorphs of atomoxetine hydrochloride |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| WO2006047493A2 (en) | 2004-10-21 | 2006-05-04 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| EP1889828A1 (en) * | 2005-04-05 | 2008-02-20 | Teva Pharmaceutical Fine Chemicals S.R.L. | Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability |
| MX2007010268A (es) * | 2005-04-05 | 2008-02-19 | Teva Pharm Fine Chemicals Srl | Clorhidrato de atomoxetina estable, un proceso para la preparacion del mismo, y un control analitico de su estabilidad. |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| US7485754B2 (en) | 2005-07-08 | 2009-02-03 | Apotex Pharmachem Inc. | Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers |
| CZ2005473A3 (cs) * | 2005-07-21 | 2006-02-15 | Zentiva, A. S | Zpusob výroby hydrochloridu (R)-N-methyl-3-(2-methylfenoxy)-3-fenylpropylaminu (atomoxetinu) |
| EP1798215A1 (en) | 2005-12-14 | 2007-06-20 | SOLMAG S.p.A. | Polymorph of atomoxetine hydrochloride in crystalline form |
| ITMI20061987A1 (it) * | 2006-10-16 | 2008-04-17 | Archimica Srl | Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine. |
| WO2008062473A1 (en) * | 2006-10-31 | 2008-05-29 | Cadila Healthcare Limited | Process for preparing atomoxetine hydrochloride |
| CN100430370C (zh) * | 2006-11-03 | 2008-11-05 | 华东理工大学 | 一种丙胺衍生物及其在制备托莫西汀中的应用 |
| WO2009141833A2 (en) * | 2008-04-17 | 2009-11-26 | Ind-Swift Laboratories Limited | An improved process for synthesizing highly pure atomoxetine |
| RU2563623C2 (ru) | 2009-12-02 | 2015-09-20 | Апталис Фарма Лимитед | Микрокапсулы фексофенадина и содержащие их композиции |
| MX365663B (es) | 2013-11-08 | 2019-06-10 | Lilly Co Eli | Solucion de atomoxetina. |
| GR1008531B (el) | 2014-03-21 | 2015-07-13 | Λαμδα Φαρμακευτικα Εργαστηρια Εφαμροσμενης Ερευνας Και Αναπτυξης Α.Ε., | Ποσιμα διαλυματα που περιεχουν υδροχλωρικη ατομοξετινη |
| EP3069715A1 (en) | 2015-03-20 | 2016-09-21 | Salmon Pharma GmbH | Immediate release dosage forms of Atomoxetine |
| CN106916074A (zh) * | 2017-02-14 | 2017-07-04 | 万特制药(海南)有限公司 | 盐酸托莫西汀的制备 |
| CN110294680A (zh) * | 2018-03-22 | 2019-10-01 | 北京深蓝海生物医药科技有限公司 | 一种盐酸阿托莫西汀的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
| US4194009A (en) * | 1974-01-10 | 1980-03-18 | Eli Lilly And Company | Aryloxyphenylpropylamines for obtaining a psychotropic effect |
| JPS5283811A (en) * | 1976-01-01 | 1977-07-13 | Lilly Co Eli | Aryloxy phenyl propylamines and their salts |
| GB1596033A (en) * | 1978-04-25 | 1981-08-19 | Boots Co Ltd | (-)-(2-methoxyphenyl) ethylamine |
| JPS5536403A (en) * | 1978-07-28 | 1980-03-14 | Nippon Iyakuhin Kogyo Kk | Preparation of 1-benzazonine derivative |
| IT1113029B (it) * | 1979-03-01 | 1986-01-20 | Simes | Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro |
-
1981
- 1981-11-12 AU AU77427/81A patent/AU540707B2/en not_active Ceased
- 1981-11-12 FI FI813589A patent/FI77018C/fi not_active IP Right Cessation
- 1981-11-12 PL PL23378681A patent/PL233786A1/xx unknown
- 1981-11-12 RO RO105785A patent/RO83309B/ro unknown
- 1981-11-12 ZA ZA817863A patent/ZA817863B/xx unknown
- 1981-11-12 CA CA000389954A patent/CA1181430A/en not_active Expired
- 1981-11-12 GR GR66518A patent/GR75395B/el unknown
- 1981-11-12 PT PT73982A patent/PT73982B/pt not_active IP Right Cessation
- 1981-11-12 NZ NZ198953A patent/NZ198953A/en unknown
- 1981-11-13 AT AT81305387T patent/ATE6422T1/de not_active IP Right Cessation
- 1981-11-13 GB GB8134282A patent/GB2087883A/en active Pending
- 1981-11-13 IE IE2661/81A patent/IE52170B1/en not_active IP Right Cessation
- 1981-11-13 ES ES507142A patent/ES8206440A1/es not_active Expired
- 1981-11-13 CS CS818359A patent/CS227019B2/cs unknown
- 1981-11-13 DD DD81234837A patent/DD201139A5/de not_active IP Right Cessation
- 1981-11-13 DE DE8181305387T patent/DE3162445D1/de not_active Expired
- 1981-11-13 SU SU813355735A patent/SU1068034A3/ru active
- 1981-11-13 EP EP81305387A patent/EP0052492B1/en not_active Expired
- 1981-11-13 JP JP56182953A patent/JPS57114555A/ja active Granted
- 1981-11-13 HU HU813411A patent/HU185475B/hu not_active IP Right Cessation
- 1981-11-13 CY CY135081A patent/CY1350A/xx unknown
- 1981-11-13 PH PH26491A patent/PH17424A/en unknown
- 1981-11-13 DK DK502781A patent/DK161887C/da active
- 1981-11-14 KR KR1019810004404A patent/KR830007508A/ko not_active Ceased
- 1981-11-14 EG EG662/81A patent/EG15458A/xx active
- 1981-11-15 IL IL64288A patent/IL64288A/xx not_active IP Right Cessation
-
1987
- 1987-02-19 HK HK160/87A patent/HK16087A/en not_active IP Right Cessation
- 1987-12-30 MY MY709/87A patent/MY8700709A/xx unknown
-
1990
- 1990-06-05 JP JP2147166A patent/JPH037250A/ja active Granted
- 1990-06-05 JP JP2147167A patent/JPH037251A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0052492B1 (en) | 3-aryloxy-3-phenylpropylamines | |
| US5245080A (en) | (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use | |
| DE69218101T2 (de) | Monofluorierte Derivate von N-Propargyl-1-Aminoindan und deren Verwendung als Monoamino-Oxidaseinhibitoren | |
| AU600839B2 (en) | Optical isomers of an imidazole derivative | |
| JP3099072B2 (ja) | （１ｓ，２ｓ）−１−（４−ヒドロキシフェニル）−２−（４−ヒドロキシ−４−フェニルピペリジン−１−イル）−１−プロパノールメタンスルホン酸塩三水和物 | |
| WO1981003491A1 (en) | Therapeutically useful tetralin derivatives | |
| US4413141A (en) | 2-(Difluoromethyl)-2,5-diaminopentanoic acid | |
| EP0284621A1 (en) | PSYCHOSTIMULATING AGENT. | |
| HU214321B (hu) | Eljárás tramadol-N-oxid-származék, enantiomerjei és ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására | |
| RU2057120C1 (ru) | N-алкил-3-фенил-3-(2-замещенный фенокси)пропиламин или его фармацевтически приемлемая кислотно-аддитивная соль, способ его получения, фармацевтическая композиция, обладающая ингибирующей поглощение норминефрина активностью | |
| US4207343A (en) | 1-Phenyl-3-(substituted phenoxy)propylamines | |
| EP0047536A2 (en) | Substituted propylamines | |
| US3991207A (en) | Combination therapy for Parkinson's disease | |
| HU190887B (en) | Process for the preparation of 2-pehnyl-methylen-cycloalkyl-amines and azetidines | |
| US4699928A (en) | Fluoroallylamine derivatives | |
| US5149714A (en) | Antidepressants | |
| GB2120244A (en) | Aminoalkadiene derivative | |
| US5266599A (en) | Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject | |
| AU614851B2 (en) | (+) 1-((3,4,5-trimethoxy)-benzyloxymethyl)-1-phenyl-n,n- dimethyl-n-propylamine, its process of preparation and its therapeutic use | |
| US4021560A (en) | 2-[(Dimethylamino)(3-pyridyl)methyl]cyclohexanol and related compounds | |
| JPH07252143A (ja) | 認知増強を誘導するベンラファキシン含有医薬組成物 | |
| EP0091437A1 (en) | Therapeutically useful tetralin derivatives iii, processes for preparation and pharmaceutical preparations for such compounds | |
| US3175945A (en) | Antihypertensive quaternary ammonium salts of 1:2:3:4-tetrahydroisoquinoline | |
| CA1245673A (en) | Medicine and its preparation | |
| EP0283551A2 (en) | Ameliorant of cerebral circulation and metabolism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |